Phylogenetic analysis of feline immunodeficiency virus in Central Europe: a prerequisite for vaccination and molecular diagnostics

References

1. Bachmann M. H., Mathiason-Dubard C., Learn G. H., Rodrigo A. G., Sodora D. L., Mazzetti P., Hoover E. A., Mullins J. I. 1997; Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J Virol 71:4241–4253
   [Google Scholar]
2. Bendinelli M., Pistello M., Lombardi S., Poli A., Garzelli C., Matteucci D., Ceccherini-Nelli L., Malvaldi G., Tozzini F. 1995; Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin Microbiol Rev 8:87–112
   [Google Scholar]
3. Bigornia L., Lockridge K. M., Sparger E. E. 2001; Construction and in vitro characterization of attenuated feline immunodeficiency virus long terminal repeat mutant viruses. J Virol 75:1054–1060
   [Google Scholar]
4. Cammarota G., Da Prato L., Nicoletti E., Matteucci D., Bendinelli M., Pistello M. 1996; Quantitation of feline immunodeficiency proviruses in doubly infected cats using competitive PCR and a fluorescence-based RFLP. J Virol Methods 62:21–31
   [Google Scholar]
5. Carpenter M. A., Brown E. W., MacDonald D. W., O'Brien S. J. 1998; Phylogeographic patterns of feline immunodeficiency virus genetic diversity in the domestic cat. Virology 251:234–243
   [Google Scholar]
6. Elyar J. S., Tellier M. C., Soos J. M., Yamamoto J. K. 1997; Perspectives on FIV vaccine development. Vaccine 15:1437–1444
   [Google Scholar]
7. English R. V., Nelson P., Johnson C. M., Nasisse M., Tompkins W. A., Tompkins M. B. 1994; Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J Infect Dis 170:543–552
   [Google Scholar]
8. Felsenstein J. 1981; Evolutionary trees from DNA sequences: a maximum likelihood approach. J Mol Evol 17:368–376
   [Google Scholar]
9. Fitch W. M. 1977; On the problem of discovering the most parsimonious tree. Am Nat 111:223–257
   [Google Scholar]
10. Graur D., Li W.-H. 2000 Fundamentals of molecular evolution , 2nd edn. Edited by Sinauer A. D., Wigg C. J. Sunderland, MA: Sinauer Associates;
    [Google Scholar]
11. Hosie M. J., Osborne R., Yamamoto J. K., Neil J. C., Jarrett O. 1995; Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines. J Virol 69:1253–1255
    [Google Scholar]
12. Hosie M. J., Flynn J. N., Rigby M. A. 9 other authors 1998; DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies. J Virol 72:7310–7319
    [Google Scholar]
13. Hosie M. J., Willett B. J., Klein D., Dunsford T. H., Cannon C., Shimojima M., Neil J. C., Jarrett O. 2002; Evolution of replication efficiency following infection with a molecularly cloned feline immunodeficiency virus of low virulence. J Virol 76:6062–6072
    [Google Scholar]
14. Kakinuma S., Motokawa K., Hohdatsu T., Yamamoto J. K., Koyama H., Hashimoto H. 1995; Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes. J Virol 69:3639–3646
    [Google Scholar]
15. Klein D., Janda P., Steinborn R., Muller M., Salmons B., Guenzburg W. H. 1999; Proviral load determination of different feline immunodeficiency virus isolates using real-time polymerase chain reaction: influence of mismatches on quantification. Electrophoresis 20:291–299
    [Google Scholar]
16. Klein D., Leutenegger C. M., Bahula C., Gold P., Hofmann-Lehmann R., Salmons B., Lutz H., Guenzburg W. H. 2001; Influence of preassay and sequence variations on viral load determination by a multiplex real-time reverse transcriptase-polymerase chain reaction for feline immunodeficiency virus. J Acquir Immune Defic Syndr 26:8–20
    [Google Scholar]
17. Kumar S., Tamura K., Jakobsen I. B., Nei M. 2001; MEGA2: molecular evolutionary genetics analysis software. Bioinformatics 17:1244–1245
    [Google Scholar]
18. Leutenegger C. M., Klein D., Hofmann-Lehmann R., Mislin C., Hummel U., Böni J., Boretti F., Guenzburg W. H., Lutz H. 1999; Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. J Virol Methods 78:105–116
    [Google Scholar]
19. Lockridge K. M., Chien M., Dean G. A., Stefano Cole K., Montelaro R. C., Luciw P. A., Sparger E. E. 2000; Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA. Virology 273:67–79
    [Google Scholar]
20. Lole K. S., Bollinger R. C., Paranjape R. S., Gadkari D., Kulkarni S. S., Novak N. G., Ingersoll R., Sheppard H. W., Ray S. C. 1999; Full-length human immunodeficiency virus type genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 73:152–160
    [Google Scholar]
21. Matteucci D., Pistello M., Mazzetti P., Giannecchini S., Del Mauro D., Zaccaro L., Bandecchi P., Tozzini F., Bendinelli M. 1996; Vaccination protects against in vivo -grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J Virol 70:617–622
    [Google Scholar]
22. Pecoraro M. R., Tomonaga K., Miyazawa T., Kawaguchi Y., Sugita S., Tohya Y., Kai C., Etcheverrigaray M. E., Mikami T. 1996; Genetic diversity of Argentine isolates of feline immunodeficiency virus. J Gen Virol 77:2031–2035
    [Google Scholar]
23. Pedersen N. C., Yamamoto J. K., Ishida T., Hansen H. 1989; Feline immunodeficiency virus infection. Vet Immunol Immunopathol 21:111–129
    [Google Scholar]
24. Pistello M., Cammarota G., Nicoletti E., Matteucci D., Curcio M., Del Mauro D., Bendinelli M. 1997; Analysis of the genetic diversity and phylogenetic relationship of Italian isolates of feline immunodeficiency virus indicates a high prevalence and heterogeneity of subtype B. J Gen Virol 78:2247–2257
    [Google Scholar]
25. Pu R., Coleman J., Omori M., Arai M., Hohdatsu T., Huang C., Tanabe T., Yamamoto J. K. 2001; Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates. AIDS 15:1225–1237
    [Google Scholar]
26. Rigby M. A., Holmes E. C., Pistello M., Mackay A., Brown A. J., Neil J. C. 1993; Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and evidence of selection for change. J Gen Virol 74:425–436
    [Google Scholar]
27. Robertson D. L., Anderson J. P., Bradac J. A. 17 other authors 1999; HIV-1 nomenclature proposal.
28. Saitou N., Nei M. 1987; The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425
    [Google Scholar]
29. Salminen M. O., Carr J. K., Burke D. S., McCutchan F. E. 1995; Identification of recombination breakpoints in HIV-1 by bootscanning. AIDS Res Hum Retroviruses 11:1423–1425
    [Google Scholar]
30. Sodora D. L., Shpaer E. G., Kitchell B. E., Dow S. W., Hoover E. A., Mullins J. I. 1994; Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol 68:2230–2238
    [Google Scholar]
31. Strimmer K., von Haeseler A. 1996; Quartet puzzling: a quartet maximum likelihood method for reconstructing tree topologies. Mol Biol Evol 13:964–969
    [Google Scholar]
32. Strimmer K., von Haeseler A. 1997; Likelihood mapping: a simple method to visualize phylogenetic content of a sequence alignment. Proc Natl Acad Sci U S A 94:6815–6819
    [Google Scholar]
33. Swofford D. L. 2002; paup*. Phylogenetic Analysis Using Parsimony (*and other methods). Version 4.0b10. Sunderland, MA: Sinauer Associates;
34. Swofford D. L., Olsen G. J., Waddell P. J., Hillis D. M. 1996; Phylogenetic inference. In Molecular Systematics , 2nd edn. pp  407–543 Edited by Hillis D. M., Moritz C., Mable B. K. Sunderland, MA: Sinauer Associates;
    [Google Scholar]
35. Tamura K., Nei M. 1993; Estimation of the number of nucleotide substitutions in the control region of mitochondrial DNA in humans and chimpanzees. Mol Biol Evol 10:512–526
    [Google Scholar]
36. Thompson J. D., Gibson T. J., Plewniak F., Jeanmougin F., Higgins D. G. 1997; The clustal x windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876–4882
    [Google Scholar]
37. Uhl E. W., Heaton-Jones T. G., Pu R., Yamamoto J. K. 2002; FIV vaccine development and its importance to veterinary and human medicine: a review. FIV vaccine 2002 update and review. Vet Immunol Immunopathol 90:113–132
    [Google Scholar]
38. Xia X., Xie Z. 2001; DAMBE: data analysis in molecular biology and evolution. J Hered 92:371–373
    [Google Scholar]
39. Yamamoto J. K., Hohdatsu T., Olmsted R. A. 7 other authors 1993; Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J Virol 67:601–605
    [Google Scholar]